Publications

5891 Results

Supplement use during an intergroup clinical trial for breast cancer (S0221)

Authors
G Zirpoli;P Brennan;C-C Hong;S McCann;G Ciupak;W Davis;J Unger;G Budd;D Hershman;HCF Moore;J Stewart;C Isaacs;T Hobday;M Salim;G Hortobagyi;J Gralow;K Albain;CB Ambrosone
Journal / Conference
Breast Cancer Research and Treatment 137(3):903-913;
Year
2013
Research Committee(s)
Breast
PMID
PMID23306462
PMC
PMC3552360
Study Number(s)
S0221

SWOG phase II trial (S0526) of pemetrexed in patients with metastatic bronchioloalveolar carinoma (BAC)

Authors
DHM Lau;J Moon;AM Davies;R Sanborn;F Hirsch;W Franklin;J Ruzich;M Redman;DR Gandara
Journal / Conference
Clinical Lung Cancer 14(4):351-355;
Year
2013
Research Committee(s)
Lung
PMID
PMID23415808
PMC
PMC4567037
Study Number(s)
S0526

Phase II trial of cisplatin plus etoposide plus gemcitabine plus solumedrol (PEGS) in peripheral T-cell non-Hodgkin Lymphoma (SWOG S0350)

Authors
D Mahadevan;J Moon;D Persky;F Young;M Leblanc;RI Fisher;TP Miller
Journal / Conference
Cancer 119(2):371-379;
Year
2013
Research Committee(s)
Lymphoma
PMID
PMID22833464
PMC
PMC3485430
Study Number(s)
S0350

Predictive factors in patients with advanced and metastatic squamous cell carcinoma of the head and neck: a study based on SWOG protocol S0420

Authors
S Mehta;M Hashmi;J Moon;M LeBlanc;CH Huang;E Rinehart;G Wolf;SG Urba;SK Banerjee;SK Williamson
Journal / Conference
Oncology Reports 29(6):2095-2100;
Year
2013
Research Committee(s)
Head and Neck
PMID
PMID23563900
PMC
PMC3694610
Study Number(s)
S0420

A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE trial

Authors
RJ Kryscio;EL Abner;FA Schmitt;P Goodman;M Mendiondo;A Caban-Holt;BC Dennis;EA Klein;JJ Crowley
Journal / Conference
Journal of Nutrition, Health and Aging 17(1):72-75;
Year
2013
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID23299383
PMC
PMC2329983
Study Number(s)
S0000A

Moving a randomized clinical trial into an observational cohort

Authors
P Goodman;J Hartline;C Tangen;J Crowley;L Minasian;E Klein;E Cook;K Anderson;M Yee;F Meyskens;L Baker
Journal / Conference
Clinical Trials 10(1):131-142;
Year
2013
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID23064404
PMC
PMC23064404
Study Number(s)
S0000

Exemestane versus anastrozole in postmenopausal women with early breast cancer:NCIC CTG MA.27, a randomized controlled phase III trial

Authors
P Goss;J Ingle;JW Chapman;MJ Ellis;GW Sledge;GT Budd;DB Johnson;M Rabaglio;K Pritchard;C Elliott;KA Gelmon;LE Shepherd
Journal / Conference
Journal of Clinical Oncology 31(11):1398-1404;
Year
2013
Research Committee(s)
Breast
PMID
PMID23358971
PMC
PMC3612593

A phase III randomized intergroup trial of CHOP chemotherapy plus rituximab compared to CHOP chemotherapy plus 131iodine-tositumomab for previously untreated follicular non-hodgkins lymphoma (SWOG S0016)

Authors
OW Press;JM Unger;L Rimsza;JW Friedberg;M LeBlanc;MS Czuczman;M Kaminski;RM Braziel;C Spier;AK Gopal;DG Maloney;B Cheson;S Dakhil;TP Miller;RI Fisher
Journal / Conference
Journal of Clinical Oncology 31(3):314-320;
Year
2013
Research Committee(s)
Lymphoma
PMID
PMID23233710
PMC
PMC3732010
Study Number(s)
S0016

A phase 3 trial of chemotherapy for anaplastic oligodendroglioma: long-terms results of RTOG 9402

Authors
G Cairncross;M Wang;E Shaw;R Jenkins;B Scheithauer;D Brachman;J Buckner;K Fink;L Souhami;N Laperriere;W Curran;M Mehta
Journal / Conference
Journal of Clinical Oncology 31(3):337-343;
Year
2013
Research Committee(s)
Brain
PMID
PMID23071247
PMC
PMC3732012

The prognostic significance of IRF8 transcripts in adult patients with acute myeloid leukemia

Authors
E Pogosova-Agadjanyan;K Kopecky;S Meshinchi;F Appelbaum;J Anderson;J Godwin;H Lee;A List;V Oehler;S Petersdorf;J Radich;C Willman;D Stirewalt
Journal / Conference
PlosOne 8(8):e70812;
Year
2013
Research Committee(s)
Leukemia
PMID
PMID23967110
PMC
PMC3743845
Study Number(s)
SWOG-9031, SWOG-9126, SWOG-9333, SWOG-9500